Back
Arcus Biosciences Vs. Entrada Therapeutics Industry Stock Comparison
Sell
21
RCUS
Arcus Biosciences
Last Price:
$8.39
Seasonality Move:
-2.74%
Buy
54
TRDA
Entrada Therapeutics
Last Price:
$7.14
Seasonality Move:
17.99%
Sell
21
Arcus Biosciences (RCUS)
is a Sell
Is Arcus Biosciences a Buy, Sell or Hold?
-
The current Arcus Biosciences [RCUS] share price is $8.59. The Score for RCUS is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
RCUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics a Buy, Sell or Hold?
-
The current Entrada Therapeutics [TRDA] share price is $7.27. The Score for TRDA is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCUS Stock Price Chart
What is Arcus Biosciences's stock price today?
-
The Arcus Biosciences share price today is $8.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCUS is experiencing slight buying pressure.
TRDA Stock Price Chart
What is Entrada Therapeutics's stock price today?
-
The Entrada Therapeutics share price today is $7.27Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing slight buying pressure.
RCUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 47.18 | Sell |
Chaikin Money Flow: | 97484 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.46 - 9.62) | Sell |
Bollinger Bands (100): | (7.81 - 10.53) | Sell |
TRDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 45.1 | Sell |
Chaikin Money Flow: | 17492 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.06 - 8.04) | Sell |
Bollinger Bands (100): | (7.4 - 11.08) | Sell |
RCUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.44 | Buy |
20-day SMA: | 8.96 | Sell |
50-day SMA: | 8.8 | Sell |
200-day SMA: | 12.47 | Sell |
8-day EMA: | 8.48 | Buy |
20-day EMA: | 8.72 | Sell |
50-day EMA: | 8.92 | Sell |
200-day EMA: | 11.54 | Sell |
TRDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.03 | Buy |
20-day SMA: | 7.45 | Sell |
50-day SMA: | 8 | Sell |
200-day SMA: | 13 | Sell |
8-day EMA: | 7.1 | Buy |
20-day EMA: | 7.35 | Sell |
50-day EMA: | 8.03 | Sell |
200-day EMA: | 11.43 | Sell |
Arcus Biosciences Earnings Growth & RCUS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.11 per share.
Entrada Therapeutics Earnings Growth & TRDA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.27 per share, a decrease this year of $4.26 per share, and a decrease next year of $0.98 per share.
Arcus Biosciences Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Entrada Therapeutics Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |